As global head of product development at Sandoz, a Novartis division, Dr. Subodh S. Deshmukh leads a team of 1000+ associates to carry out integrated product development for generic and differentiated products across the world. He oversees the strategy, performance and capability building for R&D teams including clinical, medical, technical and regulatory domains. Dr. Deshmukh also oversees the product investment strategy as a member of the Sandoz Executive Committee. His training includes a Ph.D. as Aristech Foundation Fellow from the University of Pittsburgh, USA.  He also holds an MBA with honors from the Wharton School, University of Pennsylvania, USA. In his 20 years in pharmaceutical R&D he has contributed over fifty lectures/publications, patents and brought to market multiple billion dollar products.

German-Indian Business Forum (GIBF) organises an annual German-Indian Business Forum together with the Government of India, the Bavarian Ministry of Economic Affairs, Energy and Technology, the City of Munich, Confederation of Indian Industries (CII) and OAV–German Asia-Pacific Business Association. This business forum consist of events such as Startup Connector, Business Conference & Evening Reception. These events offer a sustainable dialogue platform for top decision makers from the areas of business, politics and administration from Germany and India to consult on matters of mutual interest in Munich, the business capital of Germany.

For more detail visit: https://german-indian-forum.de/

Agenda (Times in Central European Timezone):

• 12:00 - 12:05: Introduction
• 12:05 - 12:30: Conversation with Dr. Subodh Deshmukh
• 12:30 - 12:40: Q&A
• 12:40 - 12:45: Event Closing